Novel ruthenium antimicrobial compounds.

Through exploitation of new chemical space, two antimicrobial complexes have been developed.

High activities on priority pathogens, antimicrobial efficacy and low toxicity in-vivo and ex-vivo. Low emergence of resistance and a novel target.

  • Antimicrobial compounds
  • Alternative antimicrobials

  • Bacteria

  • Human
  • Veterinary

Development stage:
  • Research
  • Development

  • Academia

  • License, Co-develop, Outsource, Joint Venture

We would like a partner to advise and assist on the next stages of our pre-clinical development plan.

Metallobio are a prospective spin out company from the University of Sheffield developing two novel antimicrobial compounds.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!